Biomarkers in Patients Undergoing Atrial Fibrillation Ablation

Universitätsklinikum Hamburg-Eppendorf

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Procedure: Catheter Ablation

Study type

Observational

Funder types

Other

Identifiers

NCT03388333

D4/17-06

Details and patient eligibility

About

The investigators aim to find biomarkers to determine the success of pulmonary vein isolation for the treatment of atrial fibrillation.

Full description

The investigators perform an observational study in patients undergoing pulmonary vein ablation to treat atrial fibrillation. Additionally, electrophysiological procedures not related to pulmonary vein isolation are also followed. The aim of the study is finding biomarkers that are able to predict short-term outcome of the procedure.The primary endpoint is defined as reoccurrences of atrial fibrillation within the first three months after pulmonary vein isolation.

Enrollment

300 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

patients with atrial fibrillation scheduled for pulmonary vein isolation with either radiofrequency of cryoballoon
patients scheduled for an electrophysiological study without ablation
patients with a catheter ablation at the cavotricuspid isthmus for the treatment of right atrial flutter

Exclusion criteria

patients with concurrent pulmonary vein isolation and ablation of the cavotricuspid isthmus
Acute myocardial infarction, coronary artery bypass graft surgery or open heart surgery within less than 3 months prior to inclusion